Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin with Brief Couples Therapy for PTSD
NCT05207436Phase 2Completed
- Sponsor
- VA San Diego Healthcare System
- Start
- Jan 2022
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxytocin nasal spray in post-traumatic stress disorder (PTSD), sponsored by VA San Diego Healthcare System. Primary endpoint: Couples Satisfaction Inventory-32 at 5 months. Started Jan 2022; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT05207436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05207436.